Garden State Investment Advisory Services LLC

Position in NVO — Novo Nordisk A S

CIK 1965351 Red Bank, NJ

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$312,856

-$174,356 QoQ

Shares Held

6,526

-7.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#878

of 1,348 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Garden State Investment Advisory Services LLC holds $6,805,871 across 6 Drug Manufacturers - General names. NVO ranks #5 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,646	$4,373,122
2	JNJ	Johnson & Johnson	3,003	$762,671
3	ABBV	AbbVie Inc.	2,515	$632,874
4	PFE	Pfizer Inc	20,511	$493,904
5	NVO	Novo Nordisk A S This page	6,526	$312,856
6	GILD	Gilead Sciences, Inc.	1,824	$230,444

All Filings in NVO

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$312,856	6,526	-7.6%	Shares	Sole	2026-08-11
2025-06-30	$487,212	7,059	+81.4%	Shares	Sole	2025-08-14
2025-03-31	$270,260	3,892	+7.5%	Shares	Sole	2025-05-15
2024-12-31	$311,306	3,619	+68.9%	Shares	Sole	2025-02-13
2024-09-30	$255,167	2,143	-5.7%	Shares	Sole	2024-12-10
2024-06-30	$324,448	2,273	-7.3%	Shares	Sole	2024-08-13
2024-03-31	$314,836	2,452	+18.5%	Shares	Sole	2024-05-14
2023-12-31	$214,038	2,069	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.